Market Research Future
Skin Graft Market is expected to expand at 13.5% CAGR during the forecast period 2019 to 2023
Skin Graft Market – Scenario The skin graft market is chiefly driven by rise in cases of accidents, burns, surgeries requiring removal of skin, skin loss due to infection such as necrotizing fasciitis or purpura fulminans and cancer etc. The rise in the number of plastic surgeries due to the growing influence of the fashion and media industry coupled with the development of tourism sector has led to the growth of the market. The global skin graft market represents a bipolar outlook with huge difference in the rural and metropolitan regions. The developed metropolitan regions especially with tourism and fashion industry sectors such as Bangkok, Las Vegas, and Los Angeles etc. have skin graft surgeries disproportionate to their population and needs. The skin graft market is led by the product development strategy which is being witnessed in the equipment section and most prominently the dermatome. Dermatome is a surgical instrument used to create thin slice the skin in skin grafting. Latest technological developments have led to the development of advanced dermatomes such as air dermatome which is more efficient and allows for greater control and accuracy in slicing skin of uniform thickness. As the use of dermatomes is dependent on the skill of the surgeons, scarcity of skilled surgeons is acting as a constraint on the global skin graft market. The market for skin graft is rising due to factors such as rise in the cases of accidents, burns and surgeries requiring removal of skin. Other factors are skin loss due to infection such as necrotizing fasciitis or purpura fulminans and cancer. The market restraints are complications such as infection, pain and cost of treatment. Considering all these factors the market for skin graft is expected to reach $ 7.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 13.5 % during 2017-2023.
Request Free Sample https://www.marketresearchfuture.com/sample_request/1674
Copy
at
Key Players Key players profiled in the report are Organogenesis, Inc., Specmed Medical, Stratatech Corp, Tissue Regenix Group PLC, Avita Medical, Convatec Inc, Medrotonic, Coloplast, B.Braun Melsungen, zimmerbiomet, Stratatech Corporation, Zimmer Biomet and others.